Easier Access to Innovative Medicines and Medical Technologies
The act introduces changes to facilitate access to new medicines and medical technologies, especially in oncology and rare diseases. It aims to make the assessment of innovative therapies faster and more efficient, potentially leading to their quicker inclusion in the reimbursement system. Citizens can expect modern treatment methods to be available in Poland more efficiently, improving healthcare quality.
Key points
Simplification of assessment procedures for new medical technologies, including medicines, by utilizing data from the European Union.
Faster inclusion of innovative medicines, particularly in oncology and rare diseases, into the list of highly innovative technologies.
The agency responsible for assessing medical technologies will consider joint clinical assessments from the EU level, speeding up the decision-making process.
60%
VOTING RESULTS
2025-07-25
For
259
Against
4
Abstain
167
Status:
Enacted
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.